Download PDF
Dtsch Med Wochenschr 2012; 137(49): 2545-2547
DOI: 10.1055/s-0032-1327267
Geriatrie | Commentary
Geriatrie
© Georg Thieme Verlag KG Stuttgart · New York

Besonderheiten bei Impfungen im höheren Lebensalter

Particuliarities of immunisation in the elderly
A. Kwetkat
1   Klinik für Geriatrie, Universitätsklinikum Jena
› Author Affiliations
Further Information

Publication History

Publication Date:
13 November 2012 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Impfungen - Immunseneszenz - Pneumokokkenimpfung

Keywords

immunisation - immunosenescense - pneumococcal vaccine
 

  • Literatur

  • 1 Beyer WEP. Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis. Vaccine 2011; 29: 5785-92
    CrossrefPubMedGoogle Scholar
  • 2 Böhmer M, Walter D. Grippeschutzimpfung in Deutschland – Ergebnisse der Studie „Gesundheit in Deutschland aktuell“ 2009. GBE Kompakt 2011; 2: 1-4
    PubMedGoogle Scholar
  • 3 Coe CL, Lubach GR, Kinnard J. Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination. Age 2012; Jan. 10 [epub ahead of print]
    PubMedGoogle Scholar
  • 4 Robert Koch-Institut. Epidemiologisches Bulletin. 2012 7. 55-56
    PubMedGoogle Scholar
  • 5 Robert Koch-Institut. Epidemiologisches Bulletin. 2012 30. 285-294
    PubMedGoogle Scholar
  • 6 Ewig S, Klapdor B, Pletz MW et al. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicenter study. Thorax 2012; 67: 132-138
    CrossrefPubMedGoogle Scholar
  • 7 Frenck RW, Yeh S. The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults. Expert Opin Biol Ther 2012; 12: 63-77
    CrossrefPubMedGoogle Scholar
  • 8 Gozalo PL, Pop-Vicas A, Feng Z et al. Effect of influenza on functional decline. J Am Geriatr Soc 2012; 60: 1260-1267
    CrossrefPubMedGoogle Scholar
  • 9 Hamza SA, Mousa SM, Taha SE et al. Immune response of 23-valent pneumococcal polysaccharide vaccinated elderly and its relation to frailty indices, nutritional status, and serum zink levels. Geriatr Gerontol Int 2012; 12: 223-229
    CrossrefPubMedGoogle Scholar
  • 10 Parodi V. Inactivated influenza vaccines: recent progress and implications for the elderly. Drugs Aging 2011; 28: 93-106
    CrossrefPubMedGoogle Scholar
  • 11 Rightmier E, Stevens V, Brown J. Streptococcus pneumoniae vaccination in older adults. Am J Geriatr Pharmacother 2011; 9: 392-404
    CrossrefPubMedGoogle Scholar
  • 12 Sanford M. Pneumococcal polysaccharide conjugate vaccine: in older adults. Drugs 2012; 72: 1243-1255
    CrossrefPubMedGoogle Scholar
  • 13 Westerink MAJ, Schroeder HW, Nahm MH. Immunse response to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. Aging and Disease 2012; 3: 51-67
    PubMedGoogle Scholar
  • 14 Weston WM, Friedland LR, Wu X et al. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): Results of two randomized trials. Vaccine 2012; 30: 1721-1728
    CrossrefPubMedGoogle Scholar
  • 15 Yao X, Hamilton RG, Wenig N et al. Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine 2011; 29: 5015-5021
    CrossrefPubMedGoogle Scholar